ArticleWorld journal of diabetes2020

Glucagon-like-1 receptor agonists and sodium/glucose cotransporter-2 inhibitors combination-are we exploiting their full potential in a real life setting?

Maja Cigrovski Berkovic et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.